Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -5.42%580.08M | -22.32%1.35B | -32.00%613.3M | -27.03%1.74B | -19.79%901.93M | -21.57%2.38B | -24.08%1.12B | 8.29%3.03B | --1.48B | 0.69%2.8B |
| Operating income | -5.42%580.08M | -22.32%1.35B | -32.00%613.3M | -27.03%1.74B | -19.79%901.93M | -21.57%2.38B | -24.08%1.12B | 8.29%3.03B | 1.48B | 0.69%2.8B |
| Cost of sales | 11.64%-379.6M | 26.23%-943.71M | 34.97%-429.58M | 29.32%-1.28B | 22.34%-660.57M | 15.12%-1.81B | 15.32%-850.59M | -11.48%-2.13B | ---1B | 3.31%-1.91B |
| Operating expenses | 11.64%-379.6M | 26.23%-943.71M | 34.97%-429.58M | 29.32%-1.28B | 22.34%-660.57M | 15.12%-1.81B | 15.32%-850.59M | -11.48%-2.13B | -1B | 3.31%-1.91B |
| Gross profit | 9.12%200.48M | -11.38%404.7M | -23.88%183.72M | -19.77%456.66M | -11.85%241.35M | -36.82%569.16M | -42.56%273.8M | 1.43%900.81M | 476.65M | 10.54%888.11M |
| Selling expenses | -17.20%-158.49M | 15.68%-311.95M | 31.66%-135.24M | 37.34%-369.94M | 27.70%-197.88M | 22.74%-590.4M | 24.93%-273.69M | -19.30%-764.21M | ---364.56M | -20.11%-640.57M |
| Administrative expenses | 18.68%-20.86M | 25.44%-47.47M | 26.30%-25.65M | 24.33%-63.66M | 0.95%-34.81M | -4.11%-84.14M | 24.25%-35.14M | 17.42%-80.82M | ---46.39M | 7.79%-97.86M |
| Research and development expenses | 8.17%-2.07M | -15.48%-4.47M | -26.60%-2.25M | 19.63%-3.87M | 35.63%-1.78M | 26.27%-4.82M | 22.55%-2.76M | 25.45%-6.53M | ---3.57M | -451.01%-8.76M |
| Impairment and provision | -82.06%-6.84M | 50.93%-11.27M | 20.31%-3.76M | -11,049.03%-22.97M | -36.37%-4.71M | 79.76%-206K | -302.33%-3.46M | 82.79%-1.02M | ---859K | -527.81%-5.91M |
| -Other impairment is provision | -82.06%-6.84M | 50.93%-11.27M | 20.31%-3.76M | -11,049.03%-22.97M | -36.37%-4.71M | 79.76%-206K | -302.33%-3.46M | 82.79%-1.02M | ---859K | -527.81%-5.91M |
| Special items of operating profit | 113.89%55K | 59.23%-1.7M | -106.66%-396K | 65.53%-4.17M | 6,897.65%5.95M | -179.43%-12.08M | -98.42%85K | 59.63%15.21M | --5.38M | -2.87%9.53M |
| Operating profit | -25.30%12.27M | 450.23%27.84M | 102.22%16.43M | 93.51%-7.95M | 119.74%8.12M | -293.05%-122.47M | -161.76%-41.17M | -56.11%63.44M | 66.65M | -15.62%144.54M |
| Financing income | -18.31%4.52M | 116.78%10.41M | 883.66%5.54M | 453.86%4.8M | 30.63%563K | -25.90%867K | 59.63%431K | 107.08%1.17M | --270K | -9.02%565K |
| Financing cost | -19.28%-3.22M | 53.62%-6M | 68.96%-2.7M | 30.46%-12.94M | -14.65%-8.69M | 32.47%-18.61M | 57.91%-7.58M | -21.08%-27.56M | ---18M | -22.32%-22.76M |
| Share of profits of associates | -101.34%-121K | 1,406.61%9.57M | 601.09%9.02M | -86.31%635K | -73.91%1.29M | -27.30%4.64M | 39.20%4.93M | -31.28%6.38M | --3.54M | 46.91%9.29M |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 55.46%-88.63M |
| Earning before tax | -52.42%13.46M | 370.59%41.82M | 2,101.17%28.29M | 88.60%-15.45M | 102.96%1.29M | -412.14%-135.58M | -182.69%-43.38M | 1.02%43.43M | 52.46M | 209.20%43M |
| Tax | 50.72%-2.26M | -157.42%-5.34M | -603.96%-4.58M | -111.08%-2.08M | -92.27%908K | 239.53%18.74M | 167.24%11.74M | 70.10%-13.43M | ---17.47M | 3.13%-44.91M |
| After-tax profit from continuing operations | -52.75%11.2M | 308.06%36.47M | 981.12%23.71M | 85.00%-17.53M | 106.93%2.19M | -489.39%-116.84M | -190.41%-31.64M | 1,667.71%30.01M | 35M | 97.77%-1.91M |
| Earning after tax | -52.75%11.2M | 308.06%36.47M | 981.12%23.71M | 85.00%-17.53M | 106.93%2.19M | -489.39%-116.84M | -190.41%-31.64M | 1,667.71%30.01M | 35M | 97.77%-1.91M |
| Minority profit | ---- | -306.54%-1.42M | -238.45%-713K | -36.30%688K | -42.71%515K | 329.30%1.08M | 431.95%899K | 42.98%-471K | --169K | -202.56%-826K |
| Profit attributable to shareholders | -54.13%11.2M | 308.00%37.89M | 1,355.42%24.42M | 84.55%-18.22M | 105.16%1.68M | -486.91%-117.92M | -193.43%-32.54M | 2,901.19%30.48M | 34.83M | 98.73%-1.09M |
| Basic earnings per share | -53.33%0.07 | 309.09%0.23 | 1,400.00%0.15 | 84.51%-0.11 | 105.00%0.01 | -455.00%-0.71 | -176.92%-0.2 | 120.20%0.2 | 0.26 | 99.14%-0.99 |
| Diluted earnings per share | -53.33%0.07 | 309.09%0.23 | 1,400.00%0.15 | 84.51%-0.11 | 105.00%0.01 | -455.00%-0.71 | -176.92%-0.2 | 120.20%0.2 | 0.26 | 99.14%-0.99 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.